v3.26.1
INCOME TAX - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Capitalized R&D Expenses $ 4,142,751 $ 4,565,699
Other Deferred Items 394,900 43,982
Stock Compensation 462,785 437,328
Net Operating Loss - US 11,963,371 8,349,314
R&D Credits 3,941,317 3,701,895
Deferred Revenue 881,229 0
Total gross deferred tax assets 21,786,353 17,098,218
Valuation Allowance (21,786,353) $ (17,098,218)
Net deferred tax assets $ 0